Skip to main content
OpenTrials

Clinical trial condition

Communicable Diseases

Explore clinical trials studying Communicable Diseases. Study availability and eligibility vary by location and protocol.

9,178 public trials 548 recruiting studies
Refine in advanced search Browse all conditions

Communicable Diseases trial results

Completed

Real World Evidence of the Effectiveness of Paritaprevir/Ritonavir (r) - Ombitasvir, + Dasabuvir Without Ribavirin in Participants With Chronic Hepatitis C and Compensated Liver Cirrhosis in the Russian Federation

NCT03053180

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +16 more
Locations
  • South-Ural State Med. Academy Chelyabinsk, Russia
  • KOGBUZ Kirovsk Infect Hosp Kirov, Russia
  • Specialized Clinical Infectiou Krasnodar, Russia
  • Orenburg Regional Clinical Hos Orenburg, Russia
View Trial Details
Completed

An Observational Study of Dual and Triple Therapies Based on Pegasys (Peginterferon Alfa-2a) in Patients With Chronic Hepatitis C

NCT01604291

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Haemek Hospital; Gastroenterology Afula, Israel
  • Barzilai MC; Gastroenterology Ashkelon, Israel
  • Soroka Medical Center; Gastroenterology Beersheba, Israel
  • Hillel Yaffe Hospital; Gastroenterology Hadera, Israel
View all 21 locations
View Trial Details
Completed

Safety and Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir and Sofosbuvir/Velpatasvir in Adults With Chronic HCV Infection Who Have Not Previously Received Treatment With Direct-Acting Antiviral Therapy

NCT02607800

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations
  • Long Beach, California, United States
  • Los Angeles, California, United States
  • Palo Alto, California, United States
  • Pasadena, California, United States
View all 93 locations
View Trial Details
Completed

Safety and Efficacy of SOF/VEL/VOX FDC for 12 Weeks and SOF/VEL for 12 Weeks in DAA-Experienced Adults With Chronic HCV Infection Who Have Not Received an NS5A Inhibitor

NCT02639247

Conditions
Blood-Borne Infections, Bronchial Diseases, Bronchiolitis, +20 more
Locations
  • Long Beach, California, United States
  • Los Angeles, California, United States
  • Palo Alto, California, United States
  • Pasadena, California, United States
View all 78 locations
View Trial Details
Completed

Safety and Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir in Adults With Chronic HCV Infection Who Have Previously Received Treatment With Direct-Acting Antiviral Therapy

NCT02607735

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations
  • Long Beach, California, United States
  • Los Angeles, California, United States
  • Palo Alto, California, United States
  • Pasadena, California, United States
View all 86 locations
View Trial Details

Related conditions